Video

Dr. Infante on the Next Step in Melanoma Research

Author(s):

Jeffrey R. Infante, MD

Dr. Jeffrey Infante from Sarah Cannon Research Institute on the Next Step in Melanoma Research

Jeffrey Infante, MD, director of drug development at the Sarah Cannon Research Institute on the next step in melanoma research.

Related Videos
Andrew Ip, MD
Mansi R. Shah, MD
Elizabeth Buchbinder, MD
Benjamin Garmezy, MD, assistant director, Genitourinary Research, Sarah Cannon Research Institute
Alec Watson, MD
Sagar D. Sardesai, MBBS
Ashkan Emadi, MD, PhD
Matthew J. Baker, PhD
Manmeet Ahluwalia, MD, MBA, FASCO
John Mascarenhas, MD
Related Content
FDA
December 20th 2024

FDA Grants Accelerated Approval to Encorafenib Plus Cetuximab and Chemo for BRAF V600E+ Metastatic Colorectal Cancer

Ongoing Research Advances Equity and Precision Oncology Through Tissue-Agnostic Therapies: With Chandler Park, MD, and Vivek Subbiah, MD
October 30th 2024

Ongoing Research Advances Equity and Precision Oncology Through Tissue-Agnostic Therapies: With Chandler Park, MD, and Vivek Subbiah, MD

Felipe Batalini, MD, of Mayo Clinic College of Medicine
December 6th 2024

Targeting PIK3CA With Allosteric Inhibitors Is Promising New Approach in Breast Cancer

OncLive On Air
September 11th 2024

Oncology Experts Preview Top Abstracts From the 2024 ESMO Congress

Francisco J. Esteva, MD, PhD
December 4th 2024

NGS and Novel Therapies Lends to Prolonged Survival Outcomes in HR+/ HER2– Breast Cancer

ReisMedia - stock.adobe.com
December 4th 2024

NICE Recommends Tebentafusp Reimbursement for HLA-A*02:01+ Uveal Melanoma